Literature DB >> 16809450

Role of tyrosine kinase receptors in angiotensin II AT2 receptor signaling: involvement in neurite outgrowth and in p42/p44mapk activation in NG108-15 cells.

Bianca Plouffe1, Marie-Odile Guimond, Hélène Beaudry, Nicole Gallo-Payet.   

Abstract

NG108-15 cells, which have a rounding-up morphology when cultured in serum-supplemented medium, extend neurites when stimulated for 3 d with angiotensin II (Ang II). The aim of the present study was to investigate whether growth factor receptors are necessary for mediating the effects of Ang II. A 3-d treatment with AG879, an inhibitor of nerve growth factor receptor TrkA, strongly affected neurite outgrowth and phosphorylation of p42/p44(mapk) induced by Ang II. PD168393, an inhibitor of epidermal growth factor (EGF) receptor slightly decreased Ang II-induced neurite outgrowth, whereas AG213, an inhibitor of both platelet-derived growth factor receptor and EGF receptor, stimulated neurite outgrowth and p42/p44(mapk) phosphorylation on its own, without affecting further stimulation with Ang II. Moreover, Ang II induced the phosphorylation of TrkA (maximum at 5 min of incubation in the presence of serum or at 20 min in cells depleted in serum for 2 h) and a rapid increase in Rap1 activity, both effects abolished in cells preincubated with 10 microm AG879. In summary, the present results demonstrate that AT(2) receptor-induced sustained activation of p42/p44(mapk) and corresponding neurite outgrowth are mediated by phosphorylation of the nerve growth factor TrkA receptor. However, the results also point out that the presence of other growth factors, such as EGF or PDFG, may interfere with the effect of Ang II. Altogether, the current findings clearly indicate that the effects of the AT(2) receptor on neurite outgrowth dynamics are modulated by the presence of growth factors in the culture medium.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16809450     DOI: 10.1210/en.2005-1315

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  11 in total

1.  Angiotensin receptor type 2 activation induces neuroprotection and neurogenesis after traumatic brain injury.

Authors:  Gali Umschweif; Sigal Liraz-Zaltsman; Dalia Shabashov; Alexander Alexandrovich; Victoria Trembovler; Michal Horowitz; Esther Shohami
Journal:  Neurotherapeutics       Date:  2014-07       Impact factor: 7.620

2.  Suppression of Resting Metabolism by the Angiotensin AT2 Receptor.

Authors:  Nicole K Littlejohn; Henry L Keen; Benjamin J Weidemann; Kristin E Claflin; Kevin V Tobin; Kathleen R Markan; Sungmi Park; Meghan C Naber; Francoise A Gourronc; Nicole A Pearson; Xuebo Liu; Donald A Morgan; Aloysius J Klingelhutz; Matthew J Potthoff; Kamal Rahmouni; Curt D Sigmund; Justin L Grobe
Journal:  Cell Rep       Date:  2016-07-28       Impact factor: 9.423

3.  Angiotensin II regulates ACE and ACE2 in neurons through p38 mitogen-activated protein kinase and extracellular signal-regulated kinase 1/2 signaling.

Authors:  Liang Xiao; Karla K V Haack; Irving H Zucker
Journal:  Am J Physiol Cell Physiol       Date:  2013-03-27       Impact factor: 4.249

4.  AT2 Receptor-Interacting Proteins ATIPs in the Brain.

Authors:  Sylvie Rodrigues-Ferreira; Erwann le Rouzic; Traci Pawlowski; Anand Srivastava; Florence Margottin-Goguet; Clara Nahmias
Journal:  Int J Hypertens       Date:  2013-01-23       Impact factor: 2.420

5.  Angiotensin II, a Neuropeptide at the Frontier between Endocrinology and Neuroscience: Is There a Link between the Angiotensin II Type 2 Receptor and Alzheimer's Disease?

Authors:  Nicole Gallo-Payet; Marie-Odile Guimond; Lyne Bilodeau; Charlotta Wallinder; Mathias Alterman; Anders Hallberg
Journal:  Front Endocrinol (Lausanne)       Date:  2011-08-26       Impact factor: 5.555

6.  Mechanisms underlying clinical efficacy of Angiotensin II type 2 receptor (AT2R) antagonist EMA401 in neuropathic pain: clinical tissue and in vitro studies.

Authors:  Uma Anand; Yiangos Yiangou; Marco Sinisi; Michael Fox; Anthony MacQuillan; Tom Quick; Yuri E Korchev; Chas Bountra; Tom McCarthy; Praveen Anand
Journal:  Mol Pain       Date:  2015-06-26       Impact factor: 3.395

Review 7.  AT(2) receptor and tissue injury: therapeutic implications.

Authors:  Pawel Namsolleck; Chiara Recarti; Sébastien Foulquier; Ulrike Muscha Steckelings; Thomas Unger
Journal:  Curr Hypertens Rep       Date:  2014-02       Impact factor: 5.369

8.  How does angiotensin AT(2) receptor activation help neuronal differentiation and improve neuronal pathological situations?

Authors:  Marie-Odile Guimond; Nicole Gallo-Payet
Journal:  Front Endocrinol (Lausanne)       Date:  2012-12-19       Impact factor: 5.555

9.  The Angiotensin II Type 2 Receptor in Brain Functions: An Update.

Authors:  Marie-Odile Guimond; Nicole Gallo-Payet
Journal:  Int J Hypertens       Date:  2012-12-25       Impact factor: 2.420

10.  Angiotensin II type 2 receptor (AT2 R) localization and antagonist-mediated inhibition of capsaicin responses and neurite outgrowth in human and rat sensory neurons.

Authors:  U Anand; P Facer; Y Yiangou; M Sinisi; M Fox; T McCarthy; C Bountra; Y E Korchev; P Anand
Journal:  Eur J Pain       Date:  2012-12-17       Impact factor: 3.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.